retatrutide news today recency 3 Today, we shared new data from two Phase trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide: FDA approval time, trial

Veljaca, Marija et al, The development of PL 14736 for treatment of inflammatory bowel disease, Advanced in GI pharmacology, 2002 O-32

GLP-1 is not a replacement for established ADHD therapies

Storage requirements after first use vary significantly between GLP-1 products , particularly between single-use and multi-dose pens: Single-use pens (used once and then discarded): Wegovy (semaglutide) : Single-use only

Ferroptosis in the metabolism of the intestinal flora in diabetes In addition to its role in the aforementioned tissues in the diabetic model, ferroptosis is also associated with intestinal flora metabolism in DM